Dr. Thomas Marron, MD

• Hematology & Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• City University Of New York School Of Medicine

  Medical School, 2012

• Impact of body mass index in patients receiving atezolizumab plus bevacizumab for hepatocellular carcinoma, 2023-04-01

• Toll-like receptor function in primary B cell defects, 2012-01-01

• NASH limits anti-tumour surveillance in immunotherapy-treated HCC, 2021-03-24

• Toll-like receptor 7 and 9 defects in common variable immunodeficiency, 2009-07-09

• Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity, 2022-01-18

• Single-cell analysis of human non-small cell lung cancer lesions refines tumor classification and patient stratification, 2021-11-11

• Early non-neutralizing, afucosylated antibody responses are associated with COVID-19 severity, 2022-03-09

• 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two National Harbor, MD, USA. 9-13 November 2016, 2016-11-16

• Molecular states during acute COVID-19 reveal distinct etiologies of long-term sequelae, 2022-12-08

• Spatial positioning and matrix programs of cancer-associated fibroblasts promote T cell exclusion in human lung tumors, 2022-11-02

• An inflammatory cytokine signature predicts COVID-19 severity and survival, 2020-08-24

• Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI Grade, 2020-07-10

• Neoadjuvant clinical trials provide a window of opportunity for cancer drug discovery, 2023-01-09

• Anti-tumor T-cell homeostatic activation is uncoupled from homeostatic inhibition by checkpoint blockade, 2019-08-02

• TLR signaling and effector functions are intact in XLA neutrophils, 2010-07-14

• Downregulation of exhausted cytotoxic T cells in gene expression networks of multisystem inflammatory syndrome in children, 2021-08-11

• Combined vaccination with NY-ESO-1 protein, poly-ICLC, and montanide improves humoral and cellular immune responses in high-risk melanoma patients, 2019-11-07

• Impact of older age in patients receiving atezolizumab and bevacizumab for hepatocellular carcinoma, 2022-09-02

• The Systemic Inflammatory Response Identifies Patients with Adverse Clinical Outcome from Immunotherapy in Hepatocellular Carcinoma, 2021-12-31

• Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinoma, 2021-04-28

• Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines, 2011-11-16